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Edited by Veli-Pekka LehtoAbstract This study addresses establishment of an ‘‘in vitro’’
melanoma angiogenesis model using multicellular tumor spher-
oids (MCTS) of diﬀerentiated (HBL) or undiﬀerentiated
(NA8) melanoma cell lines. DNA microarray assay and qRT-
PCR indicated upregulation of pro-angiogenic factors IL-8,
VEGF, Ephrin A1 and ANGPTL4 in NA8-MCTSs (vs. mono-
layers) whereas these were absent in MCTS and monolayer
cultures of HBL. Upon co-culture with endothelial cell line
HMEC-1 NA8-MCTS attract, whereas HBL-MCTS repulse,
HMEC-1. Overexpression of T-cadherin in HMEC-1 leads to
their increased invasion and network formation within NA8-
MCTS. Given an appropriate angiogenic tumor microenviron-
ment, T-cadherin upregulation on endothelial cells may potenti-
ate intratumoral angiogenesis.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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T-cadherin1. Introduction
Tumor microenvironment is a dynamic composition where
cell–cell contacts and cell-extracellular matrix adhesion take
place and soluble factor gradients are operational. These
events play critical roles in tumor initiation, progression and
metastasis. Proliferation in structured three-dimensional (3D)
architectures appears to represent a pre-requisite for can-
cer development. Single cell suspensions of tumor cells are
frequently unable to produce life threatening cancer out-
growth, while being able to induce speciﬁc immune responses,
as opposed to solid tumor fragments [1]. Our previous analyses
of gene expression proﬁles of melanoma cell lines growing in
physically diﬀerent microenvironments, namely in standardAbbreviations: MCTS, multicellular tumor spheroids; EC, endothelial
cell; HMEC-1, human microvascular EC line; T-cad, T-cadherin; CTL,
cytotoxic T lymphocytes
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oids (MCTSs), showed that structural modiﬁcations of the
architecture of tumor cell cultures alter expression of a number
of genes potentially involved in melanoma progression and
dissemination [2–4]. Additionally, MCTSs are poorly immuno-
recognized by cytotoxic T lymphocytes (CTL) speciﬁc for
tumor-associated antigens [2–4] suggesting that 3D tumor
architecture also aﬀects antigen-speciﬁc functions of CTL.
Angiogenesis represents a prerequisite for tumor growth,
invasion, progression and metastasis [5]. Cancer cells respond
to conditions of hypoxia within the tumor by producing
pro-angiogenic factors causing endothelial cell (EC) recruit-
ment and proliferation (reviewed in [6]). Since MCTSs resem-
ble in vivo cancers in their capacity to develop necrotic areas
far from nutrient and oxygen supplies, they are considered a
useful model for the study of solid tumor angiogenesis. Several
studies attempted to investigate tumor angiogenesis by either
co-culture of MCTSs with EC monolayers or EC spheroids
in vitro or implantation of MCTSs in vivo in animals
(reviewed in [7,8]); the majority of these studies have investi-
gated the inﬂuence of MCTSs on EC phenotypes and demon-
strated that EC angiogenic behaviour and characteristics of the
neovessels can be dictated by the nature of the tumor cell.
Tumor-penetrating blood vessels diﬀer morphologically and
biochemically from vessels in normal organs [9]. However,
surface molecules unequivocally speciﬁc for ECs lining
tumor-invading blood vessels have not yet been identiﬁed.
Nevertheless, also surface proteins that are substantially over-
expressed by tumor-inﬁltrating blood vessels have enormous
clinical importance. For example, the cell surface adhesion
molecules integrins avb3 and avb5 are overexpressed in the tu-
mor vasculature, and a number of inhibitors are currently
being evaluated in clinical trials (reviewed in [10,11]). Another
cell surface adhesion molecule, T-cadherin (T-cad), is upregu-
lated in tumor vasculature from murine lung metastases [12]
and human metastatic hepatocarcinomas [13,14]. Whereas
the role of integrins in tumor angiogenesis is well established
(reviewed in [15]), angiogenic properties of T-cad, an atypical
glycosylphosphatidylinositol-anchored member of the cadherin
superfamily, have only recently been appreciated. In vitro
T-cad induces angiogenic phenotypes, facilitates EC migration
[16], and stimulates in-gel outgrowth of endothelial sprouts in
EC-spheroid and heart tissue models of angiogenesis [17]. In
vivo, myoblast-mediated delivery of recombinant solubleation of European Biochemical Societies.
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ogenesis [17]. The role for T-cad in tumor angiogenesis has not
been directly investigated.
By using co-cultures of melanoma MCTSs and microvascu-
lar ECs, we (1) examined the angiogenic potential of melanoma
cells and (2) investigated the eﬀects of T-cad expression on
tumor angiogenesis. We found that melanoma cell lines at
diﬀerent stages of diﬀerentiation are endowed with distinct
angiogenic properties. Furthermore, we show that upregulation
of T-cad in ECs promotes their penetration and formation of
network structures within MCTSs from poorly diﬀerentiated
melanoma cells.2. Materials and methods
2.1. Cell culture
Melanoma cell lines were cultured in RPMI 1640 containing non-
essential aminoacids, sodium pyruvate, glutamine, HEPES buﬀer
and antibiotics and supplemented with 10% fetal calf serum [3,4]. Mul-
ticellular tumor spheroids (MCTSs) of melanoma cells were prepared
in plastic culture plates precoated with 50 mg/ml poly-2-hydroxyethyl
methacrylate (polyHEMA, Sigma–Aldrich. St. Louis, MO, USA) as
described before [3,4]. Human microvascular EC line, HMEC-1 (Pro-
moCell GmbH, Heidelberg, Germany), was cultured in EC growth
medium containing growth supplement (PromoCell) and 10% fetal calf
serum. Co-cultures of HMEC-1 and melanoma MTCSs used media
speciﬁc for either cell type at a 1:1 ratio.
2.2. Real-time RT-PCR
Total cellular RNA was extracted from melanoma cells cultured in
2D or as MCTSs and reverse transcribed. cDNA was ampliﬁed in
qRT-PCR assays as detailed before [4] in the presence of primers
and probes speciﬁc for Melan-A/MART-1, gp100 and tyrosinase,
IL-8, VEGF1 and VEGF2. Expression of house keeping gene GAPDH
was used as reference.
2.3. Co-culture and microscopy imaging
In initial experiments 3-day cultured MCTSs were placed above
HMEC-1 monolayer cultures and the behaviour of HMEC-1 cells
monitored under a phase contrast Olympus IX-50 inverted microscope
equipped with a digital camera. Subsequent experiments focused on
invasion of HMECs into MCTSs. Tumor cells prior to preparation
of MCTSs and HMEC-1 were diﬀerentially stained either with
PKH26 red ﬂuorescent cell linker (Sigma–Aldrich) or CFSE (Molecu-
lar Probes, OR, USA). HMEC-1 were seeded over labelled 3-day cul-
tured MCTSs, and images captured using laser scanning confocal
microscope Zeiss LSM 510 at diﬀerent time points.
2.4. Overexpression of T-cadherin and analysis of intra-MCTS
angiogenesis
T-cadherin was overexpressed in HMEC-1 cells by adenoviral med-
iated gene transfer as detailed before [18]. After overnight infection
with empty- or T-cad-containing adenovectors, HMEC-1 were seeded
above MCTSs. After 6 days MCTSs were collected, ﬁxed in 4% form-
aldehyde, washed in PBS, and embedded in paraﬃn [4]. Microtome
sections were examined using a Zeiss Axiophot ﬂuorescent microscope
(Zeiss, Feldbach, Switzerland) and images recorded using a digital
camera and AnalySIS software (Soft Imaging System GmbH, Mu¨n-
ster, Germany).3. Results
3.1. Selection of melanoma cell lines
Melanoma cell frequently express genes encoding enzymes
shared by untransformed melanocytes, mostly involved in
the melanogenesis process. A number of these gene products
encompass antigenic peptides recognized by CD4+ or CD8+T cells in a HLA restricted manner [19]. Notably, concordant
loss of expression of these so-called diﬀerentiation antigens is
frequently observed in metastatic lesions [20]. To identify cel-
lular reagents ‘‘bona ﬁde’’ representative of diﬀerent tumor
stages, we screened a panel (n = 15) of melanoma cell lines
for expression of gp100, Melan-A/MART-1 and tyrosinase dif-
ferentiation antigens. We identiﬁed one cell line, HBL, charac-
terized by concordant expression of these genes and one cell
line, NA8, where no speciﬁc transcripts could be ampliﬁed
(Fig. 1A). Both NA8 and HBL cell lines derive from metastatic
melanoma and have widely been used in tumor immunology
studies [2,21–23].3.2. Tumor spheroid model system
Proliferation of both NA8 and HBL cells in 2D cultures
reaches a plateau within 7 days, whereas MCTS culture
follows a slow sigmoid growth curve [3,4]. After 10–12 days
of culture necrotic cores appear within the MCTSs, resulting
in hollow centers with large, compact cells typically detectable
in the periphery (Fig. 1B). Appearance of necrotic cores might
be due to severe hypoxia (oxygen deprivation), low pH, and
nutrient starvation [6].3.3. NA8-tumor spheroids express proangiogenic molecules
We previously reported on high throughput gene expression
proﬁles in monolayer cultures and MCTSs from NA8 [4] and
HBL [3] melanoma cells. Here, to speciﬁcally evaluate the
pro-angiogenic properties of NA8 and HBL cells we compar-
atively analysed in greater detail the expression of a number
of genes whose products are known to promote angiogenesis
in cells cultured in standard monolayers and in MCTS. We
found that genes encoding proangiogenic factors IL-8, VEGF,
Ephrin A1 and Angiopoietin-like 4 protein (ANGPTL4) were
upregulated in NA8-MCTSs vs. monolayer cultures, but
absent, with the exception of ANGPTL4, in HBL cultures
(Fig. 2A). HBL-MCTS exhibited upregulation of Semaphorin
6D mRNA whereas this gene was not expressed in NA8-
MCTS.
To validate the expression proﬁle of genes encoding
pro-angiogenic factors we performed real-time quantitative
RT-PCR experiments. Data shown in Fig. 2B conﬁrm the
upregulation of IL-8, VEGF1 and VEGF2 gene expression
in NA8 cells sampled after 3-day culture in MCTS vs. mono-
layer cultures.3.4. Endothelial cells are attracted by NA8-tumor spheroids but
repulsed by HBL-tumor spheroids
Prompted by gene expression data we performed co-culture
experiments in which MCTSs from NA8 and HBL cell lines,
representative of poorly or highly diﬀerentiated melanoma
cells, respectively, were placed onto conﬂuent HMEC-1 mono-
layers. Periodic observation by phase contrast microscopy
revealed distinct eﬀects of the two types of melanoma spher-
oids on HMEC-1. HMEC-1 were repulsed by HBL-MCTS
within 6 h (Fig. 3A) but remained as an intact monolayer upon
co-culture with NA8-MCTS HMEC-1 (Fig. 3B).
To further investigate the diﬀerential response of HMEC-1
to NA8-MCTS and HBL-MCTS we performed co-culture
experiments following diﬀerential staining of melanoma cells
and HMEC-1 with either red or green ﬂuorescent dyes, respec-
tively. In these experiments HMEC-1 (green) were seeded
0.0
0.5
1.0
IL-8 VEGF-1 VEGF-2
NA8-Monolayer
NA8-MCTS
Fo
ld
 a
s 
co
m
pa
re
d 
to
 s
el
f G
AP
D
H
6not foundSemaphorin 6D
not found3.6Ephrin A1
not found3.7VEGF
334Angiopoietin like 4
not found71.4IL-8
HBL-MCTS
vs.
HBL-2D
NA8-MCTS
vs.
NA8-2D
Genes
A
B
Fig. 2. Upregulation of genes encoding pro-angiogenic factors in
NA8-MCTS. Architecture-dependent modulation of genes encoding
factors regulating angiogenesis as obtained from DNA microarray
analysis in 3-day MCTS and 2D cultures of NA8 and HBL cells (A).
Values refer to increases in expression in MCTSs relative to expression
in 2D. qRT-PCR evaluation of gene expression in NA8 cells cultured
as monolayers (open bars) or MCTSs (closed bars) for 3 days (B).
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Fig. 1. Expression of diﬀerentiation markers in HBL and NA8 melanoma cell lines and morphological features of MCTSs from HBL and NA8
melanoma cells. Expression of Melan-A/MART-1, gp100 and tyrosinase genes in 2D cultures of HBL and NA8 cells was evaluated by qRT-PCR (A).
Hematoxylin/eosin-stained sections of 10-day cultures of NA8-MCTS and HBL-MCTS show the appearance of necrotic cores (B).
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confocal microscopy after 3 days of co-culture. The images
clearly revealed deﬂection from HBL-MCTS (Fig. 3C) but
penetration of HMEC-1 into NA8-MCTS (Fig. 3D). Thus
spheroids composed of NA8 melanoma cells attract endothe-
lial cells whereas spheroids composed of HBL melanoma cells
repulse them.
3.5. Overexpression of T-cadherin in endothelial cells increases
invasion/migration into NA8 tumor spheroids
Taking advantage of the model thus established, we used
NA8 and HBL melanoma cells to investigate whether upregu-
lation of T-cadherin expression on HMEC-1 might directly
aﬀect their interaction with MCTS. HMEC-1 infected with
either empty-adenovirus (HMEC-empty-Adv) or T-cad-ade-
novirus (HMEC-T-cad-Adv) and labelled with a red ﬂuoro-
chrome were seeded above green ﬂuorochrome-labelled
tumor spheroids, and co-cultures monitored under confocal
microscopy. Invasion/migration of HMEC-1 into NA8-MCTS
was evident after 6 days of co-culture (Fig. 4). Most impor-
tantly, invasion/migration of HMEC-T-cad-Adv into NA8-
MCTS (Fig. 4C) was much more pronounced as compared
to control HMEC-empty-Adv (Fig. 4A), yielding an image
of almost uniform distribution within the spheroid. To further
evaluate the organization of HMEC-1 after invasion, micro-
tome sections of NA8-MCTS following 10 days co-culture
with ﬂuorochrome-labelled HMEC-empty-Adv or HMEC-T-
cad-Adv were prepared and examined by ﬂuorescence micros-
copy. Micrographs revealed the prominent formation of a
Fig. 3. Endothelial cells invade NA8-MCTS but not HBL-MCTS. HBL-MCTSs (A) or NA8-MCTSs (B) were placed upon HMEC-1 monolayers
and phase-contrast microscopy images taken after 6 h of co-culture. HMEC-1 pre-stained with CFSE (green ﬂuorescence) were seeded (at 10000
cells) on top of individual PKH26 (red ﬂuorescence) pre-stained HBL-MCTS (C) or NA8-MCTSs (D) confocal microscopy images were captured
after 3-days.
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T-cad overexpressing HMEC-1 within NA8-MCTS (Fig. 4D).
The inability of HMEC-1 to invade HBL tumors was not
overcome by overexpression of T-cad (data not shown). Since
neither NA8-MCTS nor HBL-MCTS expressed T-cad (data
not shown), the repulsive eﬀects of HBL-MCTS are unlikely
to be due to homophilic T-cadherin interactions and contact
inhibition [16,24–26].4. Discussion
We addressed the establishment of an ‘‘in vitro’’ melanoma
angiogenesis model. To at least in part take into account the
high heterogeneity of cancer cells, we selected a cell line,
HBL, characterized by expression of diﬀerentiation markers,
and a cell line, NA8, where this was undetectable. Hypoxia
and acidosis are microenvironmental hallmarks of solid
tumors, and our 3D MCTS model system closely simulates
such a microenvironment, as manifested by the eventual devel-
opment of an inner necrotic core upon prolonged (>10 days)
culture. Expression of pro and anti-angiogenic genes can be
triggered by metabolic stress. Our DNA microarray assay indi-
cated upregulation of several angiogenic factors, such as IL-8,
VEGF, Ephrin A1 and ANGPTL4 in NA8-derived MCTSs
(vs. 2D cultures) after only 3 days culture, which is long in
advance of formation of a necrotic core. None of these angio-genic factors, with the exception of ANGPTL4 were detectable
in either 2D or 3D cultures of the relatively diﬀerentiated
HBL-MCTS. Interestingly, HBL-MCTSs exhibited upregula-
tion of Semaphorin 6D whereas expression of this gene was ab-
sent in the relatively undiﬀerentiated NA8-MCTSs.
Consistent with the expression of angiogenic regulators in
the two melanoma-cell derived MCTSs, our investigation of
the angiogenic potential of MCTSs by co-culture with
HMEC-1 revealed pro-angiogenic properties for undiﬀerenti-
ated NA8-derived MCTSs but repulsive properties for diﬀeren-
tiated HBL-derived MCTSs. Proangiogenic activity of IL8 was
ﬁrst demonstrated by Koch et al. [27] and the role of IL8 in
tumor angiogenesis has since been well studied (reviewed in
[28]). Neutralizing antibody to IL8 inhibited tumor angiogen-
esis and concomitant metastasis in melanoma [29]. Li et al. re-
ported IL8 induced endothelial cell survival via anti-apoptotic
Bcl family members resulting in increased angiogenesis [30].
IL8 was reported to induce angiogenesis in HIF-1/VEGF
dependent fashion [31]. VEGF is one of the key regulators of
angiogenesis. Low extracellular pH can cause stress-induced
alteration in gene expression, such as upregulation of VEGF
and IL-8 in tumor cells in vitro [32]. ANGPTL4 is one of
the pro-angiogenic factors induced by hypoxia regulating angi-
ogenesis and metastasis [33].
Contact between tumor and ECs may promote toxic eﬀects.
In a study on co-culture of MCTS of malignant melanoma
cells (ST-ML-12) and ECs Oﬀner et al. observed EC death;
Fig. 4. T-cadherin facilitates endothelial cell invasiveness and network formation within NA8-MCTS. HMEC-empty-Adv or HMEC-T-cad-Adv
were stained with PKH 26 (red ﬂuorescence) and seeded on top of NA8-MCTS either prestained (A,C) or not (B,D) with CFSE (green ﬂuorescence).
Confocal microscopy images (A,C) were captured after 6 days co-culture. Fluorescence microscopy images of microtome sections of MCTS (B,D)
were taken after 10 days co-culture.
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sion of antioxidants, which rescued endothelial apoptosis [34].
The repulsive eﬀect of HBL-MCTSs in our experiments does
not reﬂect EC death. We might speculate that the repulsive ef-
fect of HBL-MCTSs could be due to their expression of Sem-
aphorin 6D. A role for Semaphorin 6D in the regulation of
angiogenesis has not yet been reported, but Semaphorin 3F
has been reported as a potent for chemorepulsant ECs.
Implantation of Semaphorin 3F-transfected cells into mice
produced a chemorepulsive eﬀect on ECs and eventually
decreased tumor metastasis [35].
The MCTS model proposed here can be exploited to address
interactions between EC and tumor cells in the presence of
altered expression of EC molecules. Evidence is mounting to
support a pro-angiogenic role for EC-expressed T-cad. Studies
in human have demonstrated upregulation of T-cad in tumor
vasculature in vivo [12–14]. Further upregulation of T-cad
has been shown to induce angiogenesis in both in vitro and
in vivo models [17,18]. However, a recent study recently using
the Matrigel-plug model of angiogenesis reported that implan-
tation of L929 cells overexpressing T-cadherin inhibited angi-
ogenesis [26]. Here, we compared the 3D-angiogenic outcome
following co-culture of MCTSs with control and T-cad over-
expressing HMEC-1. Overexpression of T-cad in HMEC-1
led to increased invasion/network formation within undiﬀeren-
tiated NA8-MCTSs but did not overcome the repulsive eﬀects
of more diﬀerentiated HBL-MCTSs, thereby suggesting that,
given an appropriate angiogenic tumor microenvironment,T-cad upregulation on EC may potentiate intratumoral angio-
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